Literature DB >> 32807991

Large-scale tethered function assays identify factors that regulate mRNA stability and translation.

En-Ching Luo1,2,3, Jason L Nathanson1,2,3, Frederick E Tan1,2,3, Joshua L Schwartz1,2,3, Jonathan C Schmok1,2,3, Archana Shankar1,2,3, Sebastian Markmiller1,2,3, Brian A Yee1,2,3, Shashank Sathe1,2,3, Gabriel A Pratt1,2,3, Duy B Scaletta1,2,3, Yuanchi Ha1,2,3, David E Hill4, Stefan Aigner1,2,3, Gene W Yeo5,6,7.   

Abstract

The molecular functions of the majority of RNA-binding proteins (RBPs) remain unclear, highlighting a major bottleneck to a full understanding of gene expression regulation. Here, we develop a plasmid resource of 690 human RBPs that we subject to luciferase-based 3'-untranslated-region tethered function assays to pinpoint RBPs that regulate RNA stability or translation. Enhanced UV-cross-linking and immunoprecipitation of these RBPs identifies thousands of endogenous mRNA targets that respond to changes in RBP level, recapitulating effects observed in tethered function assays. Among these RBPs, the ubiquitin-associated protein 2-like (UBAP2L) protein interacts with RNA via its RGG domain and cross-links to mRNA and rRNA. Fusion of UBAP2L to RNA-targeting CRISPR-Cas9 demonstrates programmable translational enhancement. Polysome profiling indicates that UBAP2L promotes translation of target mRNAs, particularly global regulators of translation. Our tethering survey allows rapid assignment of the molecular activity of proteins, such as UBAP2L, to specific steps of mRNA metabolism.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32807991      PMCID: PMC8221285          DOI: 10.1038/s41594-020-0477-6

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  77 in total

Review 1.  RNA-binding proteins in human genetic disease.

Authors:  Kiven E Lukong; Kai-wei Chang; Edouard W Khandjian; Stéphane Richard
Journal:  Trends Genet       Date:  2008-07-01       Impact factor: 11.639

Review 2.  A census of human RNA-binding proteins.

Authors:  Stefanie Gerstberger; Markus Hafner; Thomas Tuschl
Journal:  Nat Rev Genet       Date:  2014-11-04       Impact factor: 53.242

3.  The Human RNA-Binding Proteome and Its Dynamics during Translational Arrest.

Authors:  Jakob Trendel; Thomas Schwarzl; Rastislav Horos; Ananth Prakash; Alex Bateman; Matthias W Hentze; Jeroen Krijgsveld
Journal:  Cell       Date:  2018-12-06       Impact factor: 41.582

Review 4.  Evolutionary conservation and expression of human RNA-binding proteins and their role in human genetic disease.

Authors:  Stefanie Gerstberger; Markus Hafner; Manuel Ascano; Thomas Tuschl
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

5.  The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.

Authors:  Alexander G Baltz; Mathias Munschauer; Björn Schwanhäusser; Alexandra Vasile; Yasuhiro Murakawa; Markus Schueler; Noah Youngs; Duncan Penfold-Brown; Kevin Drew; Miha Milek; Emanuel Wyler; Richard Bonneau; Matthias Selbach; Christoph Dieterich; Markus Landthaler
Journal:  Mol Cell       Date:  2012-06-08       Impact factor: 17.970

6.  Insights into RNA biology from an atlas of mammalian mRNA-binding proteins.

Authors:  Alfredo Castello; Bernd Fischer; Katrin Eichelbaum; Rastislav Horos; Benedikt M Beckmann; Claudia Strein; Norman E Davey; David T Humphreys; Thomas Preiss; Lars M Steinmetz; Jeroen Krijgsveld; Matthias W Hentze
Journal:  Cell       Date:  2012-05-31       Impact factor: 41.582

7.  Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP).

Authors:  Eric L Van Nostrand; Gabriel A Pratt; Alexander A Shishkin; Chelsea Gelboin-Burkhart; Mark Y Fang; Balaji Sundararaman; Steven M Blue; Thai B Nguyen; Christine Surka; Keri Elkins; Rebecca Stanton; Frank Rigo; Mitchell Guttman; Gene W Yeo
Journal:  Nat Methods       Date:  2016-03-28       Impact factor: 28.547

8.  Purification of cross-linked RNA-protein complexes by phenol-toluol extraction.

Authors:  Erika C Urdaneta; Carlos H Vieira-Vieira; Timon Hick; Hans-Herrmann Wessels; Davide Figini; Rebecca Moschall; Jan Medenbach; Uwe Ohler; Sander Granneman; Matthias Selbach; Benedikt M Beckmann
Journal:  Nat Commun       Date:  2019-03-01       Impact factor: 14.919

9.  The RNA-binding proteomes from yeast to man harbour conserved enigmRBPs.

Authors:  Benedikt M Beckmann; Rastislav Horos; Bernd Fischer; Alfredo Castello; Katrin Eichelbaum; Anne-Marie Alleaume; Thomas Schwarzl; Tomaž Curk; Sophia Foehr; Wolfgang Huber; Jeroen Krijgsveld; Matthias W Hentze
Journal:  Nat Commun       Date:  2015-12-03       Impact factor: 14.919

10.  In-cell identification and measurement of RNA-protein interactions.

Authors:  Antoine Graindorge; Inês Pinheiro; Anna Nawrocka; Allison C Mallory; Peter Tsvetkov; Noa Gil; Carlo Carolis; Frank Buchholz; Igor Ulitsky; Edith Heard; Mikko Taipale; Alena Shkumatava
Journal:  Nat Commun       Date:  2019-11-22       Impact factor: 14.919

View more
  17 in total

Review 1.  Ubiquitin Binding Protein 2-Like (UBAP2L): is it so NICE After All?

Authors:  Lucile Guerber; Evanthia Pangou; Izabela Sumara
Journal:  Front Cell Dev Biol       Date:  2022-06-20

Review 2.  Thermostability, Tunability, and Tenacity of RNA as Rubbery Anionic Polymeric Materials in Nanotechnology and Nanomedicine-Specific Cancer Targeting with Undetectable Toxicity.

Authors:  Daniel W Binzel; Xin Li; Nicolas Burns; Eshan Khan; Wen-Jui Lee; Li-Ching Chen; Satheesh Ellipilli; Wayne Miles; Yuan Soon Ho; Peixuan Guo
Journal:  Chem Rev       Date:  2021-05-26       Impact factor: 72.087

Review 3.  Programmable technologies to manipulate gene expression at the RNA level.

Authors:  Huachun Liu; Simone Rauch; Bryan C Dickinson
Journal:  Curr Opin Chem Biol       Date:  2021-04-27       Impact factor: 8.972

Review 4.  Matrin 3 in neuromuscular disease: physiology and pathophysiology.

Authors:  Ahmed M Malik; Sami J Barmada
Journal:  JCI Insight       Date:  2021-01-11

5.  ALYREF Drives Cancer Cell Proliferation Through an ALYREF-MYC Positive Feedback Loop in Glioblastoma.

Authors:  Jianjun Wang; Yuchen Li; Binbin Xu; Jiao Dong; Haiyan Zhao; Dongxia Zhao; Yong Wu
Journal:  Onco Targets Ther       Date:  2021-01-08       Impact factor: 4.147

6.  Identification of TIA1 mRNA targets during human neuronal development.

Authors:  Loryn P Byres; Marat Mufteev; Kyoko E Yuki; Wei Wei; Alina Piekna; Michael D Wilson; Deivid C Rodrigues; James Ellis
Journal:  Mol Biol Rep       Date:  2021-08-19       Impact factor: 2.316

7.  PQN-59 antagonizes microRNA-mediated repression during post-embryonic temporal patterning and modulates translation and stress granule formation in C. elegans.

Authors:  Colleen Carlston; Robin Weinmann; Natalia Stec; Simona Abbatemarco; Francoise Schwager; Jing Wang; Huiwu Ouyang; Collin Y Ewald; Monica Gotta; Christopher M Hammell
Journal:  PLoS Genet       Date:  2021-11-22       Impact factor: 6.020

8.  Discovery and functional interrogation of SARS-CoV-2 protein-RNA interactions.

Authors:  Joy S Xiang; Jasmine R Mueller; En-Ching Luo; Brian A Yee; Danielle Schafer; Jonathan C Schmok; Frederick E Tan; Katherine Rothamel; Rachael N McVicar; Elizabeth M Kwong; Krysten L Jones; Hsuan-Lin Her; Chun-Yuan Chen; Anthony Q Vu; Wenhao Jin; Samuel S Park; Phuong Le; Kristopher W Brannan; Eric R Kofman; Yanhua Li; Alexandra T Tankka; Kevin D Dong; Yan Song; Aaron F Carlin; Eric L Van Nostrand; Sandra L Leibel; Gene W Yeo
Journal:  bioRxiv       Date:  2022-02-23

Review 9.  Circular RNA, the Key for Translation.

Authors:  Anne-Catherine Prats; Florian David; Leila H Diallo; Emilie Roussel; Florence Tatin; Barbara Garmy-Susini; Eric Lacazette
Journal:  Int J Mol Sci       Date:  2020-11-14       Impact factor: 5.923

10.  Multifunctional RNA-binding proteins influence mRNA abundance and translational efficiency of distinct sets of target genes.

Authors:  Valentin Schneider-Lunitz; Jorge Ruiz-Orera; Norbert Hubner; Sebastiaan van Heesch
Journal:  PLoS Comput Biol       Date:  2021-12-08       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.